WBA - Walgreens Boots Alliance - Stock & Dividends
Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9314271084
Pharmacy, Health, Wellness, Beauty, Personal Care, General Merchandise
Walgreens Boots Alliance Inc is a leading healthcare, pharmacy, and retail company with a global presence, operating in the United States, the United Kingdom, Germany, and other international markets.
The company's U.S. Retail Pharmacy segment is a dominant player in the retail drugstore space, offering a wide range of health and wellness services, specialty pharmacy services, and home delivery options. Its stores provide customers with a convenient and accessible way to purchase health and wellness products, beauty and personal care items, consumables, and general merchandise.
The International segment is a significant contributor to the company's revenue, with a strong presence in the United Kingdom, the Republic of Ireland, and Thailand through its Boots brand stores. Additionally, the company operates under the Benavides brand in Mexico and the Ahumada brand in Chile, offering a diverse range of prescription drugs, health and wellness products, and consumer goods.
The U.S. Healthcare segment is a key growth driver for the company, providing value-based care services through its VillageMD platform. This platform offers primary, multi-specialty, and urgent care services to patients in traditional clinic settings, as well as in-home and online appointments. The segment also includes Shields, a specialty pharmacy integrator and accelerator for hospitals, and CareCentrix, a participant in the post-acute and home care management sectors.
With a rich history dating back to 1909, Walgreens Boots Alliance Inc is headquartered in Deerfield, Illinois, and has established itself as a trusted and reliable partner in the healthcare and retail industries. For more information, visit the company's website at https://www.walgreensbootsalliance.com.
Drawdown (Underwater) Chart
WBA Stock Overview
Market Cap in USD | 7,692m |
Sector | Healthcare |
Industry | Pharmaceutical Retailers |
GiC SubIndustry | Drug Retail |
TER | 0.00% |
IPO / Inception | 1985-07-01 |
WBA Stock Ratings
Growth 5y | -82.1 |
Fundamental | -47.3 |
Dividend | 65.8 |
Rel. Performance vs Sector | -8.58 |
Analysts | 2.89/5 |
Fair Price Momentum | 8.59 USD |
Fair Price DCF | 4.07 USD |
WBA Dividends
Dividend Yield 12m | 11.77% |
Yield on Cost 5y | 2.91% |
Dividends CAGR 5y | 1.36% |
Payout Consistency | 97.7% |
WBA Growth Ratios
Growth 12m | -48.84% |
Growth Correlation 12m | -89.4% |
Growth Correlation 3m | -57.2% |
CAGR 5y | -24.37% |
CAGR/Mean DD 5y | -0.71 |
Sharpe Ratio 12m | -1.10 |
Alpha vs SP500 12m | -76.03 |
Beta vs SP500 5y weekly | 0.62 |
ValueRay RSI | 93.66 |
Volatility GJR Garch 1y | 62.03% |
Price / SMA 50 | 11.17% |
Price / SMA 200 | -31.52% |
Current Volume | 19684.1k |
Average Volume 20d | 25268.9k |
External Links for WBA Stock
Wall Street Journal • Benzinga • Yahoo Finance
Tweets
X • Stocktwits
Fund Manager Positions
Dataroma • Stockcircle
As of October 22, 2024, the stock is trading at USD 10.45 with a total of 19,684,104 shares traded.
Over the past week, the price has changed by +16.11%, over one month by +19.98%, over three months by -5.32% and over the past year by -47.43%.
According to ValueRays Forecast Model, WBA Walgreens Boots Alliance will be worth about 9.3 in October 2025. The stock is currently trading at 10.45. This means that the stock has a potential downside of -11.2%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 10.9 | 3.92 |
Analysts Target Price | 26.1 | 150 |
ValueRay Target Price | 9.3 | -11.2 |